Former Chief Medical Officer, Vice President of Nuclear Medicine, and long-time academic physician—that's our in-house nuclear medicine expert, Dr. Sandy McEwan. From research and publications in the academic space to hands-on development of novel SRTs, Sandy’s expertise is as developed as it is broad. Join Sandy and host Colin Miller on this episode of Fractals to hear key insights on: 

• The evolving landscape of nuclear medicine, radioisotope therapy, and radiopharmaceuticals in light of technological advancements, and a glimpse into their future. 
• Defining success metrics in nuclear medicine and how they are influenced by treatment modalities.
• The collaborative potential between industry and academia in advancing groundbreaking treatments and introducing new options for patients.
• The importance of prioritizing patient-centered approaches in the advancement of radiopharmaceutical therapies.